<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="Thirty years ago, just three drugs were available for the" exact="treatment" post="of viral infections, but now more than forty have"/>
 <result pre="antiviral drugs was clearly demonstrated. Acyclovir subsequently became a successful" exact="treatment" post="for HSV-1 and HSV-2. The success of acyclovir provided"/>
 <result pre="for clinical use, was azidothymidine (AZT), which emerged from a" exact="screening" post="effort of around 100 nucleoside analogues selected by Wellcome"/>
 <result pre="the era of highly active antiretroviral therapy (HAART), transforming HIV" exact="infection" post="from a death sentence to a chronically manageable disease."/>
 <result pre="classes and new classes of drugs from both more serendipitous" exact="screening" post="and rational design have been developed. Twenty-four anti-HIV drugs"/>
 <result pre="pharmacological defences against an influenza pandemic. Also, the compounds and" exact="treatment" post="strategies developed for HIV could be considered as a"/>
 <result pre="a paradigm for the development of similar approaches for the" exact="treatment" post="of other viral infections, in particular hepatitis C virus"/>
 <result pre="researchers to identify and develop new therapies, harnessing both 'serendipitous'" exact="screening" post="strategies and rational design, as exemplified in the discovery"/>
</results>
